October 31, 2025 · Form 4 insider transaction
Paolini John F. bought 36,542 shares of Kiniksa Pharmaceuticals Ltd. at $3.80 per share, a transaction worth $138.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on July 30, 2025.